Related Experiment Video
Updated: Jan 7, 2026

08:09
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
9.9K
A Reproducible Sequence-Level Strategy to Enhance Peptide Immunogenicity While Preserving Wild-Type Epitope
Chia-Hung Chen1,2, Yu-Chi Chiu3, Kai-Yao Huang1,2,4,5
1Department of Medical Research, Hsinchu MacKay Memorial Hospital, Hsinchu 30071, Taiwan.
Antibodies (Basel, Switzerland)
|December 24, 2025
Summary
Researchers developed a workflow to enhance peptide immunogenicity for antibody generation. Strategic sequence edits boost antibody production while maintaining recognition of original epitopes, overcoming limitations in antibody development.
Area of Science:
- Immunology
- Peptide Chemistry
Background:
- Short peptide epitopes are crucial for mechanistic studies but often exhibit low immunogenicity.
- Lack of commercially available antibodies against short peptides impedes rapid antibody generation.
Purpose of the Study:
- To develop a reproducible workflow for enhancing peptide immunogenicity.
- To generate epitope-directed antibodies when commercial reagents are unavailable.
Main Methods:
- A sequence-level workflow integrating cross-species/structural triage and MHC-I/II prioritization.
- Conservative heteroclitic-style substitutions to enhance predicted MHC affinity.
- Conjugation of optimized peptides to KLH for antibody induction in mice.
Main Results:
- Optimized peptides demonstrated improved MHC-binding predictions.
- Enhanced antibody titers and isotype maturation (increased IgG1) were observed.
- Generated antibodies retained binding to wild-type sequences, confirming cross-recognition.
Conclusions:
- Strategic, minimal sequence edits significantly enhance peptide immunogenicity.
- Preservation of native epitope recognition is achievable with this method.
- This workflow offers a low-barrier approach for generating custom peptide antibodies.
Keywords:
conservative (heteroclitic) mutagenesiscross-reactive antibodiespeptide immunogenicitysequence-level antigen engineering
